Product
Interferon gamma-primed mesenchymal stromal cells
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A Phase 1 Study to Evaluate Safety, Toxicity, and Potential Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent AsthmaStatus: Recruiting, Estimated PCD: 2025-07-01